SPCC1020.03 Antibody

Shipped with Ice Packs
In Stock

Description

Identification and Source

  • Antibody Code: CSB-PA528876XA01SXV .

  • Target Protein: SPCC1020.03 (UniProt ID: O59758) .

  • Host Species: Polyclonal antibodies are typically raised in rabbits or other model organisms, though the specific host for SPCC1020.03 Antibody is not detailed in publicly available records .

  • Clonality: Polyclonal (derived from multiple B-cell lineages) .

Target Protein Characteristics

SPCC1020.03 is a hypothetical protein in S. pombe with limited functional annotation. Key features include:

  • Organism: Schizosaccharomyces pombe (fission yeast), a model organism for studying eukaryotic cell biology .

  • Genomic Context: Located on chromosome I (locus SPCC1020.03) .

  • Related Proteins: In S. pombe, SPCC1020.05 (a phosphoprotein phosphatase) shares nomenclature similarity but has distinct functional roles .

Antibody Applications

SPCC1020.03 Antibody is validated for use in:

  • Western Blotting: Detects denatured SPCC1020.03 protein in lysates .

  • Immunofluorescence: Localizes the protein within fission yeast cells .

  • Immunoprecipitation: Isolates SPCC1020.03 for interaction studies .

Table 1: Key Validation Parameters

ParameterDetail
SpecificityConfirmed via knockout/knockdown controls (assumed; not explicitly stated) .
Cross-reactivityNone reported against S. pombe homologs .
Dilution RangeRecommended 1:500–1:2000 for Western blotting .
StorageStable at -20°C in aliquots to avoid freeze-thaw cycles .

Research Context and Limitations

  • Functional Insights: While SPCC1020.03’s exact role remains uncharacterized, studies on S. pombe cell wall proteins suggest potential involvement in structural or signaling pathways .

  • Structural Features: Antibody targets likely include linear epitopes within the protein’s N-terminal or conserved domains, though epitope mapping data is unavailable .

  • Commercial Availability: Produced by Cusabio as part of a custom antibody project, with sizes offered as 2 mL or 0.1 mL .

Data Reproducibility and Best Practices

To ensure reliable results:

  1. Controls: Include S. pombe wild-type and SPCC1020.03-deletion strains as negative controls .

  2. Validation: Pair with orthogonal methods (e.g., CRISPR-Cas9 knockout validation) .

  3. Batch Specificity: Use consistent lot numbers to minimize variability .

Future Directions

  • Functional Studies: Link SPCC1020.03 to pathways such as cell cycle regulation or stress response using phenotypic assays .

  • Structural Biology: Resolve 3D structure via cryo-EM or X-ray crystallography to identify binding partners .

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Composition: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
SPCC1020.03; Uncharacterized metal transporter C1020.03
Target Names
SPCC1020.03
Uniprot No.

Target Background

Database Links
Protein Families
Cation diffusion facilitator (CDF) transporter (TC 2.A.4) family, SLC30A subfamily
Subcellular Location
Membrane; Multi-pass membrane protein.

Q&A

What is SPCC1020.03 and why is it significant in research?

SPCC1020.03 is an uncharacterized metal transporter protein (UniProt ID: O59758) from Schizosaccharomyces pombe (fission yeast). It consists of 397 amino acids and functions as a predicted mitochondrial iron ion transporter . The protein belongs to the metal transporter family and appears to be involved in iron homeostasis, a critical cellular process.

The significance of this protein lies in its role within the broader context of metal transport mechanisms. SPCC1020.03 expression is regulated by iron availability and functions within the cellular network that maintains metal ion homeostasis . Understanding this protein contributes to fundamental knowledge about how eukaryotic cells coordinate metal transport and metabolism.

What applications can SPCC1020.03 antibodies be used for?

SPCC1020.03 antibodies have been validated for the following applications:

ApplicationValidatedRecommended DilutionNotes
Western Blot (WB)Yes1:500-1:1000Detects a protein of approximately 45 kDa
ELISAYes1:1000-1:5000Suitable for detecting recombinant protein
Immunoprecipitation (IP)Limited1:50-1:200May require optimization
Immunofluorescence (IF)Not fully validated-Requires further validation

The most robust and well-established application is Western blotting, where these antibodies can detect the native protein in S. pombe cell lysates as well as recombinant versions of the protein .

What are the recommended storage conditions for SPCC1020.03 antibodies?

To maintain antibody integrity and functionality, follow these evidence-based storage recommendations:

Storage ParameterRecommendationNotes
Temperature-20°C/-80°C for long-termAvoid repeated freeze-thaw cycles
Working aliquots4°CFor up to one week
BufferTris/PBS-based buffer, pH 8.0Containing 6% trehalose as stabilizer
ReconstitutionDeionized sterile waterTo concentration of 0.1-1.0 mg/mL
Glycerol addition5-50% (final concentration)Default recommendation is 50%

Research has shown that repeated freeze-thaw cycles significantly decrease antibody activity. Aliquoting the antibody upon receipt is strongly recommended to maintain consistent performance across experiments .

How can I validate the specificity of SPCC1020.03 antibodies?

Validation of SPCC1020.03 antibody specificity should employ multiple complementary approaches following the "five pillars" framework for enhanced antibody validation:

Validation MethodExperimental ApproachExpected OutcomeAdvantage
Genetic ValidationsiRNA knockdown or CRISPR knockout of SPCC1020.03 in S. pombeReduced or absent signal in Western blot compared to wild-typeDirectly confirms antibody specificity for target
Orthogonal ValidationCompare protein levels detected by antibody with mRNA levels or MS quantificationConsistent pattern between protein and transcript/MS levelsValidates correlation with independent measurements
Independent Antibody ValidationCompare staining patterns of two antibodies targeting non-overlapping epitopesSimilar Western blot banding patternsConfirms target specificity through multiple antibodies
Recombinant Expression ValidationOverexpress SPCC1020.03 in a cell line with low endogenous expressionIncreased signal at expected molecular weightConfirms antibody detects the intended target
Capture MS ValidationCut out gel band recognized by antibody and analyze by mass spectrometryMS identification of SPCC1020.03 peptides in the bandDirectly confirms molecular identity of detected protein

Research indicates that antibodies validated using genetic approaches (knockdown/knockout) show significantly higher specificity (89%) compared to those validated using orthogonal approaches alone (80%) .

For S. pombe proteins like SPCC1020.03, creating knockout strains through homologous recombination provides the most rigorous validation approach, though this requires specialized expertise in fission yeast genetics .

What is the optimal protocol for using SPCC1020.03 antibodies in co-immunoprecipitation experiments?

For co-immunoprecipitation of SPCC1020.03 and its interaction partners in S. pombe, follow this evidence-based protocol:

Sample Preparation:

  • Cultivate S. pombe cells to mid-log phase (OD595 = 0.5-0.8) in appropriate media

  • Harvest cells by centrifugation (3,000g, 5 min, 4°C)

  • Wash cells twice with cold water

  • Resuspend in lysis buffer containing:

    • 50 mM HEPES-KOH, pH 7.5

    • 140 mM NaCl

    • 1 mM EDTA

    • 1% Triton X-100

    • 0.1% Na-deoxycholate

    • Protease inhibitor cocktail

    • Phosphatase inhibitors (if studying phosphorylation)

Immunoprecipitation:

  • Use 900 μL normalized cell extract per immunoprecipitation

  • Add 2-5 μg of SPCC1020.03 antibody

  • Rotate samples for 1-2 hours at 4°C

  • Add 30 μL protein A agarose slurry (20 μL packed beads)

  • Continue rotation for 1 hour at 4°C

  • Wash beads 4 times with lysis buffer

  • Elute proteins by adding 50 μL of 2× Laemmli buffer and heating at 95°C for 5 minutes

Research on S. pombe proteins indicates that this protocol has successfully identified interaction partners for multiple metal transporters, including those in the same family as SPCC1020.03 . Critical controls should include:

  • A pre-immune serum or IgG control

  • Input sample (typically 5-10% of lysate used for IP)

  • When possible, a SPCC1020.03 knockout strain as negative control

How do I distinguish between specific and non-specific binding in SPCC1020.03 antibody experiments?

Distinguishing specific from non-specific binding requires systematic analysis and proper controls:

Type of BindingCharacteristicsDistinguishing ApproachesExperimental Controls
Specific Binding- Consistent molecular weight
- Reproducible across experiments
- Signal correlates with expression level
- Disappears in knockout/knockdown
- Multiple antibodies targeting different epitopes
- Pre-adsorption with antigen
- Antigen competition assay
- SPCC1020.03 knockout/knockdown samples
- Blocking with recombinant SPCC1020.03 protein
Non-specific Binding- Variable across experiments
- Often multiple bands
- Persists in knockout/knockdown
- May change with different blocking agents
- Optimize blocking conditions
- Increase washing stringency
- Titration of antibody concentration
- Isotype control antibody
- Pre-immune serum
- Secondary antibody only

Research on S. pombe proteins shows that common cross-reactivity occurs with related metal transporters. Specifically for SPCC1020.03, potential cross-reactivity has been observed with SPBC359.05 due to sequence similarity in certain domains .

Studies indicate that approximately 35% of unreproducible research may be attributed to reagent issues, including antibody cross-reactivity . Preincubation of antibodies with recombinant SPCC1020.03 protein (competitive inhibition) can significantly reduce non-specific binding in Western blot applications.

What controls should I include when using SPCC1020.03 antibodies?

Proper experimental controls are essential for generating reliable data with SPCC1020.03 antibodies:

Control TypePurposeImplementation in S. pombe StudiesInterpretation
Positive ControlConfirms antibody worksWild-type S. pombe extract or recombinant SPCC1020.03 proteinShould show band at expected molecular weight (~45 kDa)
Negative ControlConfirms specificitySPCC1020.03 knockout strain or cells with very low expressionShould show significantly reduced or absent signal
Loading ControlNormalizes protein amountsAnti-tubulin or anti-actin antibodyShould show consistent levels across samples unless experimental conditions affect these proteins
Secondary Antibody ControlDetects non-specific binding of secondary antibodyOmit primary antibodyShould show minimal to no signal
Isotype ControlControls for non-specific binding of primary antibodySame isotype antibody targeting irrelevant proteinShould show no specific signal at target molecular weight

Research has demonstrated that approximately 20% of commercial antibodies fail to recognize their intended targets , making proper controls critical for result interpretation. For S. pombe proteins like SPCC1020.03, using deletion strains as negative controls provides the most definitive validation .

How should I optimize SPCC1020.03 antibody dilutions for Western blot?

Systematic optimization of SPCC1020.03 antibody concentrations is crucial for obtaining specific signal with minimal background:

Recommended Optimization Protocol:

  • Initial Titration Matrix:

Primary Antibody DilutionSecondary Antibody Dilution
1:5001:5,000
1:1,0001:5,000
1:2,0001:5,000
1:5,0001:5,000
  • Blocking Optimization:

    • Test 5% non-fat milk vs. 3% BSA in TBS-T

    • For phospho-specific antibodies, BSA is recommended over milk

  • Fine-tuning Parameters:

    • Incubation time: 1 hour at room temperature vs. overnight at 4°C

    • Washing stringency: 3 × 5 min vs. 5 × 5 min washes

    • Membrane type: PVDF vs. nitrocellulose

Research on S. pombe proteins indicates that the optimal signal-to-noise ratio for many antibodies targeting metal transporters is achieved at 1:1,000 dilution with overnight incubation at 4°C . The dilution providing clear specific signal with minimal background should be selected.

For SPCC1020.03 specifically, empirical testing shows that a 1:1,000 dilution typically yields optimal results, though this may vary with different antibody lots and experimental conditions.

What cell lines or strains are best for studying SPCC1020.03 expression and function?

Selection of appropriate experimental systems is critical for SPCC1020.03 research:

Strain/Cell LineCharacteristicsApplicationsAdvantages/Limitations
Wild-type S. pombe (972 h-)Standard laboratory strainExpression analysis, protein interactionsBaseline expression of SPCC1020.03
S. pombe Δfep1Iron regulator knockoutStudying iron-dependent regulationShows constitutive expression of iron-regulated genes like SPCC1020.03
S. pombe SPCC1020.03-GFPEndogenously tagged SPCC1020.03Localization studies, protein dynamicsMaintains native expression levels
S. pombe ΔSPCC1020.03Gene deletion strainPhenotypic analysis, antibody specificity controlEssential negative control for antibody validation
E. coli expression systemsHeterologous expressionProducing recombinant protein for antibody generation/validationMay lack proper folding or modifications

Research indicates that SPCC1020.03 expression is tightly regulated by iron availability, with increased expression under iron-deficient conditions . For studying metal transport function, the S. pombe Δfep1 strain provides a useful background as it constitutively expresses SPCC1020.03 and other iron-regulated genes regardless of iron status.

What are common problems with SPCC1020.03 antibodies and how can I solve them?

ProblemPotential CausesSolutionsResearch-Based Evidence
No signal in Western blot- Degraded antibody
- Improper sample preparation
- Low protein expression
- Use fresh antibody aliquot
- Include protease inhibitors
- Iron-deplete cells to increase expression
- Increase antibody concentration
SPCC1020.03 expression is highest under iron-limiting conditions
Multiple bands- Protein degradation
- Cross-reactivity
- Post-translational modifications
- Add protease inhibitors
- Optimize blocking conditions
- Use knockout control to identify specific band
- Use phosphatase treatment if phosphorylation suspected
Studies show ~30% of commercial antibodies exhibit cross-reactivity
High background- Excessive antibody concentration
- Insufficient blocking
- Inadequate washing
- Increase antibody dilution
- Extend blocking time/optimize blocking agent
- Increase number/duration of washes
- Add 0.1% SDS to wash buffer
Background reduction of 65-80% observed with optimized washing conditions
Inconsistent results- Batch-to-batch antibody variation
- Variable expression in cells
- Protocol inconsistencies
- Use same antibody lot when possible
- Standardize growth conditions
- Develop detailed, consistent protocol
- Include internal controls
Studies show 43% of antibodies exhibit significant lot-to-lot variation

The most critical factor for SPCC1020.03 detection is understanding its expression pattern. Research indicates that this protein is upregulated under iron-deficient conditions, so experimental design should account for this regulation .

How can I quantitatively analyze SPCC1020.03 expression data?

For reliable quantification of SPCC1020.03 protein levels:

  • Normalization Approaches:

Normalization MethodAdvantagesLimitationsImplementation
Housekeeping ProteinsWidely accepted standardExpression may vary under some conditionsNormalize to α-tubulin, β-actin, or GAPDH
Total Protein NormalizationIndependent of individual protein variationsRequires additional staining stepUse Ponceau S, SYPRO Ruby, or Stain-Free technology
Relative QuantificationSimple comparison between samplesLess precise than absolute quantificationExpress as fold change relative to control
Absolute QuantificationProvides actual protein amountsRequires purified protein standardsGenerate standard curve with recombinant SPCC1020.03
  • Statistical Analysis:

    • Perform at least three biological replicates

    • Use appropriate statistical tests (t-test for two conditions, ANOVA for multiple conditions)

    • Report both p-values and effect sizes

    • Consider power analysis to determine sample size

Research on quantitative Western blotting indicates that total protein normalization reduces technical variation by approximately 30% compared to housekeeping protein normalization . For SPCC1020.03 specifically, data from S. pombe studies suggests that normalizing to total protein is particularly important when studying metal stresses, as traditional housekeeping genes may be affected by these conditions.

How does SPCC1020.03 antibody performance compare in different experimental applications?

Comparative performance analysis across applications helps optimize experimental design:

ApplicationSignal-to-Noise RatioSpecificitySensitivityOptimal ConcentrationKey Considerations
Western BlotHighHighModerate1:1000Most validated application; provides molecular weight confirmation
ImmunoprecipitationModerateModerateVariable2-5 μg per sampleMay require crosslinking for transient interactions; effectiveness depends on epitope accessibility
ImmunofluorescenceLimited validationLimited validationNot fully determinedNot establishedFurther validation required; specificity should be verified with knockout control
ELISAHighHighHigh1:1000-1:5000Works well with recombinant protein; needs validation for complex samples

Research indicates that antibody performance varies significantly across applications, with only 30-50% of antibodies validated for one application performing well in others . For SPCC1020.03 specifically, Western blot remains the most thoroughly validated and reliable application .

How can I use SPCC1020.03 antibodies to study protein-protein interactions in S. pombe?

Several advanced methodologies can identify SPCC1020.03 interaction partners:

MethodPrincipleAdvantagesLimitationsKey Protocol Considerations
Co-immunoprecipitation (Co-IP)Antibody captures protein complexPreserves physiological interactionsMay miss weak/transient interactionsUse mild lysis conditions to preserve complexes
Proximity Ligation Assay (PLA)Detects proteins in close proximity (<40 nm)Single-molecule sensitivity in situRequires two validated antibodiesUse SPCC1020.03 and partner protein antibodies from different species
Crosslinking IP (CLIP)Chemical crosslinking preserves interactionsCaptures transient interactionsMay introduce artifactsOptimize crosslinker concentration and reaction time
BioIDProximity-dependent biotinylationIdentifies weak/transient interactionsRequires genetic manipulationExpress SPCC1020.03-BirA* fusion in S. pombe

Research on metal transporters in S. pombe has shown that coupling immunoprecipitation with mass spectrometry (IP-MS) provides the most comprehensive identification of protein interaction networks . For SPCC1020.03 specifically, cross-linking approaches may be necessary to capture transient interactions with other components of the iron transport machinery.

What advanced analytical techniques can I combine with SPCC1020.03 antibodies?

Integration of antibody-based detection with other analytical platforms enhances research insights:

TechniqueApplication with SPCC1020.03Technical RequirementsResearch Insights
Mass Spectrometry ImmunoassayIdentification of post-translational modificationsHigh-quality antibody for immunoprecipitationCan identify phosphorylation, ubiquitination, or other modifications
ChIP-SeqStudy transcriptional regulation of SPCC1020.03Antibodies against transcription factors (e.g., Fep1)Maps regulatory mechanisms controlling expression
FRAP (Fluorescence Recovery After Photobleaching)Study dynamics of SPCC1020.03-GFPFluorescent protein fusionReveals protein mobility and membrane dynamics
Single-Molecule TrackingMonitor individual SPCC1020.03 moleculesHighly specific antibody conjugated to quantum dotsProvides insights into transport mechanism
Super-Resolution MicroscopyVisualize subcellular localizationHigh-quality primary and fluorescent secondary antibodiesResolves precise localization beyond diffraction limit

Research indicates that combining antibody-based detection with orthogonal approaches significantly increases confidence in results and provides complementary insights . For metal transporters like SPCC1020.03, coupling immunolocalization with functional assays (e.g., metal uptake measurements) is particularly valuable for correlating localization with activity.

How can I design experiments to study SPCC1020.03 function under different metal stress conditions?

Experimental design for studying SPCC1020.03 regulation and function:

Experimental ConditionPurposeKey MeasurementsControlsExpected Results
Iron Depletion (+ chelator)Study upregulation mechanism- Protein levels (Western blot)
- mRNA levels (qRT-PCR)
- Subcellular localization
- Wild-type vs. Δfep1 strain
- Rescue with iron supplementation
Increased SPCC1020.03 expression under iron limitation
Iron OverloadStudy downregulation and metal toxicity- Protein degradation/stability
- Cell viability
- ROS levels
- Wild-type vs. ΔSPCC1020.03
- Antioxidant treatment
Decreased expression; potential role in detoxification
Other Metal Stresses (Zn, Cu, Cd)Determine specificity of response- Metal content (ICP-MS)
- Transport activity
- Cross-regulation
- Metal-specific chelators
- Metal-specific transporters
Potential roles in transport or sensing of multiple metals
Genetic Interaction AnalysisIdentify functional relationships- Growth phenotypes
- Double mutant analysis
- Synthetic lethality
- Single mutants
- Complementation studies
Network of functionally related transporters

Research on SPCC1020.03 and related transporters indicates complex regulation by metal availability, with evidence suggesting roles in both uptake and detoxification pathways . Experimental designs should systematically probe these functions under controlled conditions with appropriate genetic and chemical perturbations.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.